Area of research
Pulmonary and Respiratory Medicine · Physiology
Research interest
Research interests include Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery, and Respiratory and Cough-Related Research.
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS
Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
Predicting Pneumonia Events in COPD Patients Using Medical Records
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)
Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Late Breaking Abstract - Pneumonia risk in COPD patients initiating extrafine Fixed Dose Combination (FDC) with beclometasone dipropionate (ef-FDC-BDP) versus long-acting bronchodilators (LABD)
Late Breaking Abstract - Comparing pneumonia risk in COPD patients initiating Fixed Dose Combination (FDC) inhaler comprising extrafine beclometasone dipropionate versus fluticasone
Effect of airway acidosis and alkalosis on airway vascular smooth muscle responsiveness to albuterol